Jin Medical International Ltd.
ZJYL
$0.34
$0.00-0.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.21% | -2.35% | 30.83% | 8.92% | -10.51% |
| Total Depreciation and Amortization | 36.41% | 43.97% | 53.32% | 12.31% | -15.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.29% | -20,635.71% | -296.75% | -221.72% | -169.13% |
| Change in Net Operating Assets | 69.54% | -105.66% | -2,350.10% | -2,543.64% | -606.98% |
| Cash from Operations | 215.88% | -97.24% | -138.87% | -110.62% | -90.56% |
| Capital Expenditure | -1,032.05% | -650.90% | -27.02% | -119.47% | -404.32% |
| Sale of Property, Plant, and Equipment | -100.00% | -98.06% | -96.08% | 3.85% | 5,100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.93% | -33.08% | -22.85% | 5.05% | 34.95% |
| Cash from Investing | -98.80% | -52.11% | -23.08% | 3.79% | 32.82% |
| Total Debt Issued | 107.86% | 140.63% | 198.00% | 271.31% | 538.76% |
| Total Debt Repaid | -75.07% | -34.35% | 5.53% | -88.77% | -4,957.02% |
| Issuance of Common Stock | -100.00% | -96.53% | -96.26% | -94.12% | -91.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | 119.13% | 89.37% | 68.64% | 8.79% | -41.48% |
| Foreign Exchange rate Adjustments | 80.40% | 159.80% | 282.40% | 107.53% | 43.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,082.91% | 48.79% | -43.54% | -80.54% | -96.22% |